JOYY (YY) Competitors

Medpace (NASDAQ:MEDP) and JOYY (NASDAQ:YY) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, community ranking, dividends and institutional ownership.

Do institutionals and insiders believe in MEDP or YY?

78.0% of Medpace shares are owned by institutional investors. Comparatively, 36.8% of JOYY shares are owned by institutional investors. 20.3% of Medpace shares are owned by insiders. Comparatively, 43.0% of JOYY shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Is MEDP or YY more profitable?

Medpace has a net margin of 19.17% compared to JOYY's net margin of 9.02%. Medpace's return on equity of 51.48% beat JOYY's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	19.17%	51.48%	20.47%
JOYY	9.02%	4.64%	2.96%

Does the MarketBeat Community believe in MEDP or YY?

JOYY received 201 more outperform votes than Medpace when rated by MarketBeat users. Likewise, 67.03% of users gave JOYY an outperform vote while only 63.54% of users gave Medpace an outperform vote.

Company	Underperform	Outperform
Medpace	Outperform Votes 352 63.54%	Underperform Votes 202 36.46%
JOYY	Outperform Votes 553 67.03%	Underperform Votes 272 32.97%

Do analysts recommend MEDP or YY?

Medpace presently has a consensus target price of $381.44, indicating a potential upside of 16.89%. JOYY has a consensus target price of $35.00, indicating a potential downside of 28.70%. Given Medpace's stronger consensus rating and higher possible upside, research analysts plainly believe Medpace is more favorable than JOYY.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.45
JOYY	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Which has better valuation & earnings, MEDP or YY?

Medpace has higher earnings, but lower revenue than JOYY. JOYY is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.11B	4.71	$404.39M	$12.63	25.84
JOYY	$2.26B	1.17	$301.82M	$3.31	14.83

Which has more risk & volatility, MEDP or YY?

Medpace has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, JOYY has a beta of 0.21, suggesting that its stock price is 79% less volatile than the S&P 500.

Does the media prefer MEDP or YY?

In the previous week, Medpace had 10 more articles in the media than JOYY. MarketBeat recorded 16 mentions for Medpace and 6 mentions for JOYY. Medpace's average media sentiment score of 1.39 beat JOYY's score of 0.78 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	12 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
JOYY	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Medpace beats JOYY on 14 of the 18 factors compared between the two stocks.